Related Experiment Video
Updated: Mar 19, 2026

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
Published on: June 28, 2013
LDL Receptor: An open route to feed pancreatic tumor cells
Sophie Vasseur1, Fabienne Guillaumond1
1INSERM, U1068, Centre de Recherche en Cancérologie de Marseille, Marseille, France; Institut Paoli-Calmettes, Marseille, France; CNRS, UMR7258, Marseille, France; Université Aix-Marseille, Marseille, France.
Abstract:
The role of altered lipid metabolism in pancreatic ductal adenocarcinoma (PDAC) is poorly appreciated. We recently identified the lipid signature of PDAC and revealed low-density lipoprotein receptor (Ldlr) as a metabolic driver of this disease. Here, we comment our findings that disruption of Ldlr leads to intratumoral cholesterol imbalance and improves chemotherapy efficiency.
Related Concept Videos
Receptor-mediated Endocytosis
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Insulin: The Receptor and Signaling Pathways

